Linklaters’ IP lawyers, many of whom have scientific and technical backgrounds, work closely with leading multinational companies to enforce and exploit their intellectual property rights.
Linklaters’ IP lawyers, many of whom have scientific and technical backgrounds, work closely with leading multinational companies to enforce and exploit their intellectual property rights. The team’s industry sector expertise includes a strong focus on healthcare, banking, telecoms and IT.
The team advises on national and international IP enforcement strategies for clients and defends their IP rights vigorously where necessary. Linklaters maximises the commercial value of clients’ IP assets and wards off unwelcome claims from third parties. Clients depend on the experience of Linklaters’ lawyers in major patent and trade mark litigation cases, often on a multi-jurisdictional basis.
Linklaters’ IP lawyers are widely acknowledged for their support of significant M&A and capital markets deals, and on high-profile and complex corporate insolvencies. A substantial proportion of the team’s commercial workload therefore involves multi-jurisdictional issues.
The team also focuses on R&D, agency, distribution, franchising, sponsorship and other licensing agreements, as well as the related antitrust issues that arise.
Recent IP transactions include advising:
- on landmark patent cases Actavis v Merck (involving pharmaceuticals and second medical use) and Aerotel v Telco (concerning telecommunications and testing patentability)
- on the trade mark dispute Direct Line v esure
- Shire on a complex sub-licensing structure and outsourcing concerning its Gastro Intestinal Tract drug
- Bayer on the acquisition of DIREVO Biotech AG, a significant biotech transaction
- Deloitte & Touche LLP on IP issues in the insolvencies of Woolworths and Waterford Wedgwood